ClinicalTrials.govpublic full text
A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's Disease
crohn's disease, olokizumab, okz, cdp6038, cdai, ibdq, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 858278
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.